These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31423659)

  • 1. VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.
    Hartmann L; Botzanowski T; Galibert M; Jullian M; Chabrol E; Zeder-Lutz G; Kugler V; Stojko J; Strub JM; Ferry G; Frankiewicz L; Puget K; Wagner R; Cianférani S; Boutin JA
    Protein Sci; 2019 Oct; 28(10):1865-1879. PubMed ID: 31423659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VHH characterization.Recombinant VHHs: Production, characterization and affinity.
    Chabrol E; Stojko J; Nicolas A; Botzanowski T; Fould B; Antoine M; Cianférani S; Ferry G; Boutin JA
    Anal Biochem; 2020 Jan; 589():113491. PubMed ID: 31676284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery.
    Kijanka M; Warnders FJ; El Khattabi M; Lub-de Hooge M; van Dam GM; Ntziachristos V; de Vries L; Oliveira S; van Bergen En Henegouwen PM
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1718-29. PubMed ID: 23778558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
    Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab's epitope with versatile biochemical, biological, and medical applications.
    Nikkhoi SK; Heydarzadeh H; Vandavasi VG; Yang G; Louro P; Polunas M; Owji H; Hatefi A
    Immunol Res; 2024 Feb; 72(1):103-118. PubMed ID: 37632647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept.
    Khoshtinat Nikkhoi S; Rahbarizadeh F; Ahmadvand D; Moghimi SM
    Eur J Pharm Sci; 2018 Sep; 122():42-50. PubMed ID: 29933078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of camelid single-domain antibodies against HER2.
    Hussack G; Raphael S; Lowden MJ; Henry KA
    BMC Res Notes; 2018 Dec; 11(1):866. PubMed ID: 30518413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-survivin single-domain antibodies derived from an artificial library including three synthetic random regions by in vitro selection using cDNA display.
    Suzuki T; Mochizuki Y; Kimura S; Akazawa-Ogawa Y; Hagihara Y; Nemoto N
    Biochem Biophys Res Commun; 2018 Sep; 503(3):2054-2060. PubMed ID: 30119893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirror-Image Single-Domain Antibody for a Novel Nonimmunogenic Drug Scaffold.
    Aoki K; Manabe A; Kimura H; Katoh Y; Inuki S; Ohno H; Nonaka M; Oishi S
    Bioconjug Chem; 2023 Nov; 34(11):2055-2065. PubMed ID: 37883660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
    De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
    Front Immunol; 2019; 10():2920. PubMed ID: 31921179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consensus protocol for the in silico optimisation of antibody fragments.
    Soler MA; Medagli B; Semrau MS; Storici P; Bajc G; de Marco A; Laio A; Fortuna S
    Chem Commun (Camb); 2019 Nov; 55(93):14043-14046. PubMed ID: 31690899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity.
    Ji X; Lu W; Zhou H; Han D; Yang L; Wu H; Li J; Liu H; Zhang J; Cao P; Zhang S
    Appl Microbiol Biotechnol; 2013 Oct; 97(19):8547-58. PubMed ID: 23324801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.
    Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C
    Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
    Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and identification of single-domain antibody fragment against capsid protein of porcine circovirus type 2 (PCV2) from C. bactrianus.
    Yang S; Shang Y; Yin S; Tian H; Chen Y; Sun S; Jin Y; Liu X
    Vet Immunol Immunopathol; 2014 Jul; 160(1-2):12-9. PubMed ID: 24736187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein.
    Mortelecque J; Zejneli O; Bégard S; Simões MC; ElHajjar L; Nguyen M; Cantrelle FX; Hanoulle X; Rain JC; Colin M; Gomes CM; Buée L; Landrieu I; Danis C; Dupré E
    J Biol Chem; 2024 Apr; 300(4):107163. PubMed ID: 38484799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and In Vitro Function of Anti-Breast Cancer Llama-Based Single Domain Antibody VHH Expressed in Tobacco Plants.
    Park SR; Lee JH; Kim K; Kim TM; Lee SH; Choo YK; Kim KS; Ko K
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of similar single domain antibodies from two immune VHH libraries obtained from two alpacas by using different selection methods.
    Li T; Vandesquille M; Bay S; Dhenain M; Delatour B; Lafaye P
    Immunol Lett; 2017 Aug; 188():89-95. PubMed ID: 28690185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal nanoparticle armed with bivalent bispecific single-domain antibodies, novel weapon in HER2 positive cancerous cell lines targeting.
    Nikkhoi SK; Rahbarizadeh F; Ranjbar S; Khaleghi S; Farasat A
    Mol Immunol; 2018 Apr; 96():98-109. PubMed ID: 29549861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
    Hussack G; Ryan S; van Faassen H; Rossotti M; MacKenzie CR; Tanha J
    PLoS One; 2018; 13(12):e0208978. PubMed ID: 30540857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.